Dopamine Replacement Medication Does Not Influence Implicit Learning of a Stepping Task in People With Parkinson’s Disease

Serene S. Paul, Sydney Schaefer, Genevieve N. Olivier, Christopher S. Walter, Keith R. Lohse, Leland E. Dibble

Research output: Contribution to journalArticle

Abstract

Introduction. Treatment of Parkinson’s disease (PD) with exogenous dopamine (ie, levodopa) may positively affect motor symptoms, but may negatively affect other functions such as the learning of motor skills necessary for rehabilitation. This study aimed to determine whether levodopa medication affects general and sequence-specific learning of a stepping task and the transfer of movement skill to untrained balance tasks in people with PD. Methods. Participants with PD were randomized to practice “on” (n = 14) or “off” (n = 13) levodopa medication. Participants practiced 6 blocks of 6 trials of 24 steps of a stepping task over an acquisition period of 3 consecutive days, followed by single retention blocks of 6 trials 2 and 9 days later. Participants were also assessed on untrained balance (ie, transfer) tasks “on” levodopa before practice and following late retention. Results. There were no between-group differences in general learning, sequence-specific learning, or transfer of skill to untrained balance tasks (P >.05). Both groups demonstrated general and sequence-specific learning (P <.001) and trends for improvement in untrained tasks (P <.001 to P =.26) following practice. Detailed analysis of early acquisition revealed no difference between medication groups. Conclusion. People with PD improved performance on the stepping task with practice. The between-group effect sizes were small, suggesting that levodopa medication status (“on” versus “off”) during practice did not significantly affect general or sequence-specific learning of the task or components of early acquisition. The practice dose required to optimally result in functional improvements in untrained balance tasks, including reductions in falls, remains to be determined.

Original languageEnglish (US)
Pages (from-to)1031-1042
Number of pages12
JournalNeurorehabilitation and Neural Repair
Volume32
Issue number12
DOIs
StatePublished - Dec 1 2018

Fingerprint

Levodopa
Parkinson Disease
Dopamine
Learning
Motor Skills
Rehabilitation
Practice (Psychology)
Transfer (Psychology)
Retention (Psychology)

Keywords

  • balance
  • levodopa medication
  • motor learning
  • Parkinson disease
  • rehabilitation
  • transfer

ASJC Scopus subject areas

  • Rehabilitation
  • Neurology
  • Clinical Neurology

Cite this

Dopamine Replacement Medication Does Not Influence Implicit Learning of a Stepping Task in People With Parkinson’s Disease. / Paul, Serene S.; Schaefer, Sydney; Olivier, Genevieve N.; Walter, Christopher S.; Lohse, Keith R.; Dibble, Leland E.

In: Neurorehabilitation and Neural Repair, Vol. 32, No. 12, 01.12.2018, p. 1031-1042.

Research output: Contribution to journalArticle

Paul, Serene S. ; Schaefer, Sydney ; Olivier, Genevieve N. ; Walter, Christopher S. ; Lohse, Keith R. ; Dibble, Leland E. / Dopamine Replacement Medication Does Not Influence Implicit Learning of a Stepping Task in People With Parkinson’s Disease. In: Neurorehabilitation and Neural Repair. 2018 ; Vol. 32, No. 12. pp. 1031-1042.
@article{f74079ae9fb94aa18ea009318fc84092,
title = "Dopamine Replacement Medication Does Not Influence Implicit Learning of a Stepping Task in People With Parkinson’s Disease",
abstract = "Introduction. Treatment of Parkinson’s disease (PD) with exogenous dopamine (ie, levodopa) may positively affect motor symptoms, but may negatively affect other functions such as the learning of motor skills necessary for rehabilitation. This study aimed to determine whether levodopa medication affects general and sequence-specific learning of a stepping task and the transfer of movement skill to untrained balance tasks in people with PD. Methods. Participants with PD were randomized to practice “on” (n = 14) or “off” (n = 13) levodopa medication. Participants practiced 6 blocks of 6 trials of 24 steps of a stepping task over an acquisition period of 3 consecutive days, followed by single retention blocks of 6 trials 2 and 9 days later. Participants were also assessed on untrained balance (ie, transfer) tasks “on” levodopa before practice and following late retention. Results. There were no between-group differences in general learning, sequence-specific learning, or transfer of skill to untrained balance tasks (P >.05). Both groups demonstrated general and sequence-specific learning (P <.001) and trends for improvement in untrained tasks (P <.001 to P =.26) following practice. Detailed analysis of early acquisition revealed no difference between medication groups. Conclusion. People with PD improved performance on the stepping task with practice. The between-group effect sizes were small, suggesting that levodopa medication status (“on” versus “off”) during practice did not significantly affect general or sequence-specific learning of the task or components of early acquisition. The practice dose required to optimally result in functional improvements in untrained balance tasks, including reductions in falls, remains to be determined.",
keywords = "balance, levodopa medication, motor learning, Parkinson disease, rehabilitation, transfer",
author = "Paul, {Serene S.} and Sydney Schaefer and Olivier, {Genevieve N.} and Walter, {Christopher S.} and Lohse, {Keith R.} and Dibble, {Leland E.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1177/1545968318809922",
language = "English (US)",
volume = "32",
pages = "1031--1042",
journal = "Neurorehabilitation and Neural Repair",
issn = "1545-9683",
publisher = "SAGE Publications Inc.",
number = "12",

}

TY - JOUR

T1 - Dopamine Replacement Medication Does Not Influence Implicit Learning of a Stepping Task in People With Parkinson’s Disease

AU - Paul, Serene S.

AU - Schaefer, Sydney

AU - Olivier, Genevieve N.

AU - Walter, Christopher S.

AU - Lohse, Keith R.

AU - Dibble, Leland E.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Introduction. Treatment of Parkinson’s disease (PD) with exogenous dopamine (ie, levodopa) may positively affect motor symptoms, but may negatively affect other functions such as the learning of motor skills necessary for rehabilitation. This study aimed to determine whether levodopa medication affects general and sequence-specific learning of a stepping task and the transfer of movement skill to untrained balance tasks in people with PD. Methods. Participants with PD were randomized to practice “on” (n = 14) or “off” (n = 13) levodopa medication. Participants practiced 6 blocks of 6 trials of 24 steps of a stepping task over an acquisition period of 3 consecutive days, followed by single retention blocks of 6 trials 2 and 9 days later. Participants were also assessed on untrained balance (ie, transfer) tasks “on” levodopa before practice and following late retention. Results. There were no between-group differences in general learning, sequence-specific learning, or transfer of skill to untrained balance tasks (P >.05). Both groups demonstrated general and sequence-specific learning (P <.001) and trends for improvement in untrained tasks (P <.001 to P =.26) following practice. Detailed analysis of early acquisition revealed no difference between medication groups. Conclusion. People with PD improved performance on the stepping task with practice. The between-group effect sizes were small, suggesting that levodopa medication status (“on” versus “off”) during practice did not significantly affect general or sequence-specific learning of the task or components of early acquisition. The practice dose required to optimally result in functional improvements in untrained balance tasks, including reductions in falls, remains to be determined.

AB - Introduction. Treatment of Parkinson’s disease (PD) with exogenous dopamine (ie, levodopa) may positively affect motor symptoms, but may negatively affect other functions such as the learning of motor skills necessary for rehabilitation. This study aimed to determine whether levodopa medication affects general and sequence-specific learning of a stepping task and the transfer of movement skill to untrained balance tasks in people with PD. Methods. Participants with PD were randomized to practice “on” (n = 14) or “off” (n = 13) levodopa medication. Participants practiced 6 blocks of 6 trials of 24 steps of a stepping task over an acquisition period of 3 consecutive days, followed by single retention blocks of 6 trials 2 and 9 days later. Participants were also assessed on untrained balance (ie, transfer) tasks “on” levodopa before practice and following late retention. Results. There were no between-group differences in general learning, sequence-specific learning, or transfer of skill to untrained balance tasks (P >.05). Both groups demonstrated general and sequence-specific learning (P <.001) and trends for improvement in untrained tasks (P <.001 to P =.26) following practice. Detailed analysis of early acquisition revealed no difference between medication groups. Conclusion. People with PD improved performance on the stepping task with practice. The between-group effect sizes were small, suggesting that levodopa medication status (“on” versus “off”) during practice did not significantly affect general or sequence-specific learning of the task or components of early acquisition. The practice dose required to optimally result in functional improvements in untrained balance tasks, including reductions in falls, remains to be determined.

KW - balance

KW - levodopa medication

KW - motor learning

KW - Parkinson disease

KW - rehabilitation

KW - transfer

UR - http://www.scopus.com/inward/record.url?scp=85058725967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058725967&partnerID=8YFLogxK

U2 - 10.1177/1545968318809922

DO - 10.1177/1545968318809922

M3 - Article

VL - 32

SP - 1031

EP - 1042

JO - Neurorehabilitation and Neural Repair

JF - Neurorehabilitation and Neural Repair

SN - 1545-9683

IS - 12

ER -